Patients with severe COVID-19 with IFNAR1 deficiency treated with IFN-γ showed increased oxygen saturation (SpO2) to 94% in the nine days of hospitalization [37]. This evidence concerns the gene IFNAR1 and hyperinsulinemic hypoglycemia, familial, 4.